These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20005928)

  • 1. In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends.
    Cheng L; Lei L; Guo S
    Int J Pharm; 2010 Mar; 387(1-2):129-38. PubMed ID: 20005928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and in vitro release of praziquantel from poly(epsilon-caprolactone) implants.
    Cheng L; Guo S; Wu W
    Int J Pharm; 2009 Jul; 377(1-2):112-9. PubMed ID: 19446618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants.
    Li C; Cheng L; Zhang Y; Guo S; Wu W
    Int J Pharm; 2010 Feb; 386(1-2):23-9. PubMed ID: 19895876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel.
    Passerini N; Albertini B; Perissutti B; Rodriguez L
    Int J Pharm; 2006 Aug; 318(1-2):92-102. PubMed ID: 16697539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ethylene glycol) layered silicate nanocomposites for retarded drug release prepared by hot-melt extrusion.
    Campbell K; Craig DQ; McNally T
    Int J Pharm; 2008 Nov; 363(1-2):126-31. PubMed ID: 18657600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amphiphilic PCL-PEG-PCL copolymer addition on 5-fluorouracil release from biodegradable PCL films for stent application.
    Lu F; Lei L; Shen YY; Hou JW; Chen WL; Li YG; Guo SR
    Int J Pharm; 2011 Oct; 419(1-2):77-84. PubMed ID: 21803141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melt granulation using a twin-screw extruder: a case study.
    Van Melkebeke B; Vermeulen B; Vervaet C; Remon JP
    Int J Pharm; 2006 Dec; 326(1-2):89-93. PubMed ID: 16949222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored protein release from biodegradable poly(ε-caprolactone-PEG)-b-poly(ε-caprolactone) multiblock-copolymer implants.
    Stanković M; Tomar J; Hiemstra C; Steendam R; Frijlink HW; Hinrichs WL
    Eur J Pharm Biopharm; 2014 Jul; 87(2):329-37. PubMed ID: 24602675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced in vivo absorption of CB-1 antagonist in rats via solid solutions prepared by hot-melt extrusion.
    Ranzani LS; Font J; Galimany F; Santanach A; Gomez-Gomar AM; Casadevall G; Gryczke A
    Drug Dev Ind Pharm; 2011 Jun; 37(6):694-701. PubMed ID: 21226628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution.
    Orlandi S; Priotti J; Diogo HP; Leonardi D; Salomon CJ; Nunes TG
    AAPS PharmSciTech; 2018 Apr; 19(3):1274-1286. PubMed ID: 29313262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of gentamicin sulphate from biodegradable PLGA-implants produced by hot melt extrusion.
    Gosau M; Müller BW
    Pharmazie; 2010 Jul; 65(7):487-92. PubMed ID: 20662316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels.
    Zhang Y; Wu X; Han Y; Mo F; Duan Y; Li S
    Int J Pharm; 2010 Feb; 386(1-2):15-22. PubMed ID: 19895878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue anti-adhesion potential of ibuprofen-loaded PLLA-PEG diblock copolymer films.
    Lee JH; Go AK; Oh SH; Lee KE; Yuk SH
    Biomaterials; 2005 Feb; 26(6):671-8. PubMed ID: 15282145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
    Ahuja N; Katare OP; Singh B
    Eur J Pharm Biopharm; 2007 Jan; 65(1):26-38. PubMed ID: 16962750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: Drug release, microstructure, and ex vivo permeation behaviors.
    Lei L; Liu X; Guo S; Tang M; Cheng L; Tian L
    J Control Release; 2010 Aug; 146(1):45-53. PubMed ID: 20566400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on hydrophilic 5-fluorouracil release from hydrophobic poly(ε-caprolactone) cylindrical implants.
    Hou J; Li C; Cheng L; Guo S; Zhang Y; Tang T
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1068-75. PubMed ID: 21449700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo protein delivery from in situ forming poly(ethylene glycol)-poly(lactide) hydrogels.
    Hiemstra C; Zhong Z; Van Tomme SR; van Steenbergen MJ; Jacobs JJ; Otter WD; Hennink WE; Feijen J
    J Control Release; 2007 Jun; 119(3):320-7. PubMed ID: 17475360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.